Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

Company Overview - Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company focused on developing novel oral small molecule therapeutics for metabolic diseases, particularly obesity [1][3] - The company utilizes a next-generation structure-based drug discovery platform to create a robust GPCR-targeted pipeline, featuring multiple proprietary clinical-stage oral small molecule compounds [3] Upcoming Events - Management will participate in the Cantor Global Healthcare Conference on September 3 at 3:55 p.m. ET in New York, NY, featuring a fireside chat and 1x1 meetings [2] - The company will also attend the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10 at 10:45 a.m. ET, also in New York, NY, with a similar format [2] - Live and archived webcasts of these events will be available on the company's website for 90 days [2]